Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Buspirone in the Treatment of 2-6 Year Old Children With Autistic Disorder (B-ACE)

This study has been completed.
Sponsor:
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by (Responsible Party):
Diane C Chugani, Wayne State University
ClinicalTrials.gov Identifier:
NCT00873509
First received: March 30, 2009
Last updated: July 25, 2016
Last verified: July 2016